Gastro-enteropancreatic neuroendocrine tumor
Other Names for this Disease
- GEP tumors
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- ClinicalTrials.gov lists trials that are studying or have studied Gastro-enteropancreatic neuroendocrine tumor. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
Somatuline® Depot (injection)
The FDA has approved this product to be used in this manner.
|Long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy. Treatment of patients with unresectable,well- or moderately-differentiated locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors to improve progression-free survival.|
|More Information about this product||Drug Information Portal|